NEW

ETHICON LAUNCHES VISTASEAL FIBRIN SEALANT

Many patients today are entering the operating room with multiple factors that can cause disruptive bleeding during surgery, which can be challenging to manage and potentially dangerous. To help address this, Johnson & Johnson Medical Devices Companies* announced...

Going digital: Using real data to prevent infection

By Dustin Rahlf, Director of Healthcare Digital Solutions at Ecolab While AI & robot enabled surgeries are capturing headlines, real-time digital dashboards and predictive analytics may be the overshadowed sidekick that enables a safer operating room (OR). It is...

AORN Updates Guideline on Sterilization Packaging

By Susan Klacik The primary objective of sterilization packaging is to maintain the sterile integrity of the packaged contents until they are used. Many factors influence this outcome and the Association of periOperative Registered Nurses’ (AORN’s) newly updated...

ASCs Embrace Nation’s Renewed Focus on Healthcare Quality

By Bill Prentice As the Democratic presidential candidates continue to define their plans for delivering affordable, accessible healthcare and members of Congress on both sides of the aisle continue to explore ways to cut the cost of that care without sacrificing...

Getinge Group appoints new President of Acute Care Therapies Business Category Unit

Getinge Group has appointed Jens Viebke as the new President of the Acute Care Therapies Business Category Unit. Viebke will be a member of the Getinge Group Executive Team and succeeds Heinz Jacqui who will step down from his current position after four years with the group. Acute care therapies is one of Getinge’s three business category units and is responsible for developing technologies and solutions for cardiac, pulmonary and vascular therapies and products and therapies for intensive care.

The group has made significant investments in quality management systems in recent years, particularly in areas related to the acute care therapies business category unit.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X